Saint Agnes Cancer Center at Saint Agnes Medical Center
Fresno, California, United States
Cancer treatment center in Fresno, California
7130 N Millbrook Ave, Fresno, CA 93720
About Saint Agnes Cancer Center at Saint Agnes Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Radiation Therapy Oncology Group
3
Clinical Trials at Saint Agnes Cancer Center at Saint Agnes Medical Center
During the past decade, Saint Agnes Cancer Center at Saint Agnes Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
2007-11-01
2022-05-20
Completed
544
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
2008-06-01
2022-05-20
Completed
344
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
2010-03-01
2016-12-01
Completed
97
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Agnes Cancer Center at Saint Agnes Medical Center"
#1 collaborator was "NRG Oncology" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Saint Agnes Cancer Center at Saint Agnes Medical Center
According to Clinical.Site data, the most researched conditions in "Saint Agnes Cancer Center at Saint Agnes Medical Center" are
"Lung Cancer" (2 trials), "Esophageal Cancer" (1 trials) and "Radiation Toxicity" (1 trials). Many other conditions were trialed in "Saint Agnes Cancer Center at Saint Agnes Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Saint Agnes Cancer Center at Saint Agnes Medical Center
Most popular intervention types in "Saint Agnes Cancer Center at Saint Agnes Medical Center" are "Radiation" (3 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "60 Gy RT" (1 trials), "74 Gy RT" (1 trials), "Carboplatin" (1 trials), "Cetuximab" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saint Agnes Cancer Center at Saint Agnes Medical Center
The vast majority of trials in "Saint Agnes Cancer Center at Saint Agnes Medical Center" are
3 trials for "All" genders.
Clinical Trials Status at Saint Agnes Cancer Center at Saint Agnes Medical Center
Currently, there are NaN active trials in "Saint Agnes Cancer Center at Saint Agnes Medical Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Saint Agnes Cancer Center at Saint Agnes Medical Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saint Agnes Cancer Center at Saint Agnes Medical Center, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".